3609:
Late Breaking Oral Abstract Session: Clinical Science
Sunday, March 4, 2018: 2:00 PM-3:15 PM
Convention Center, South Concourse, Level 1, South Hall A1
Oral Session
1.25 CME/CE
Primary Moderators:
Antonella Cianferoni, MD PhD FAAAAI
Mimi L. K. Tang, MBBS PhD FAAAAI
2:00 PM
L6
Efficacy and Safety of AR101 in Peanut Allergy: Results from a Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial (PALISADE)
Stacie M. Jones, MD, FAAAAI
2:15 PM
L7
Recent Trends in Fatalities, Waiting Times, and Use of Epinephrine Auto-Injectors for Subcutaneous Allergen Immunotherapy (SCIT): AAAAI/ACAAI National Surveillance Study 2008-2016
Tolly Epstein, MD FAAAAI
2:30 PM
L8
Introduction of Allergen-Containing Foods: Feeding Infants and Toddlers Study (FITS) 2016
Marion E. Groetch, MS RDN
2:45 PM
L9
Sensitization and Exposure to Other Indoor Allergens May Attenuate the Clinical Benefit of Mouse Allergen Reduction Among Mouse-Sensitized Urban Children with Asthma
Sara C Sadreameli, MD, MHS
3:00 PM
L10
Associations between Total and Speciated Pollen Counts and Several Morbidity Measures in the Contiguous United States from 2008 to 2015
Jeremy J. Hess, MD MPH